RESEARCH AND DEVELOPMENT EXPENSES (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Statement [Line Items] | |||
| Research and development expenses | $ 1,223 | $ 2,910 | $ 2,763 |
| Research and Development Program [Member] | |||
| Statement [Line Items] | |||
| Research and development expenses | 0 | 0 | 0 |
| Alzheimers Disease Therapeutics [Member] | |||
| Statement [Line Items] | |||
| Research and development expenses | 0 | 0 | 0 |
| Anti-Infectives [Member] | |||
| Statement [Line Items] | |||
| Research and development expenses | 0 | 0 | 0 |
| BPH (Enlarged Prostate) and Prostate Cancer Therapeutics [Member] | |||
| Statement [Line Items] | |||
| Research and development expenses | 1,223 | 2,910 | 2,763 |
| Tobacco Exposure Tests: NicAlert? and TobacAlert? [Member] | |||
| Statement [Line Items] | |||
| Research and development expenses | $ 0 | $ 0 | $ 0 |